Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 8.

Röhn, T A; Ralvenius, W T; Paul, J; Borter, P; Hernandez, M; Witschi, R; Grest, P; Zeilhofer, H U; Bachmann, M F; Jennings, G T (2011). A Virus-Like particle-based anti-nerve growth factor vaccine reduces inflammatory hyperalgesia: potential long-term therapy for chronic pain. Journal of Immunology, 186(3):1769-1780.

Witschi, R; Punnakkal, P; Paul, J; Walczak, J S; Cervero, F; Fritschy, J M; Kuner, R; Keist, R; Rudolph, U; Zeilhofer, H U (2011). Presynaptic {alpha}2-GABAA receptors in primary afferent depolarization and spinal pain control. Journal of Neuroscience, 31(22):8134-8142.

Witschi, R; Johansson, T; Morscher, G; Scheurer, L; Deschamps, J; Zeilhofer, H U (2010). Hoxb8-CreMice: A tool for brain-sparing conditional gene deletion. Genesis, 48(10):596-602.

Witschi, R. GABAA receptor subtypes in spinal pain processing. 2010, D-CHAB, ETHZ.

Pernía-Andrade, A J; Kato, A; Witschi, R; Nyilas, R; Katona, I; Freund, T F; Watanabe, M; Filitz, J; Koppert, W; Schüttler, J; Ji, G; Neugebauer, V; Marsicano, G; Lutz, B; Vanegas, H; Zeilhofer, H U (2009). Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization. Science, 325(5941):760-764.

Zeilhofer, H U; Witschi, R; Johansson, T (2009). Fast inhibitory transmission of pain in the spinal cord. In: Malcangio, M. Synaptic Plasticity in Pain. London: Springer, 49-66.

Zeilhofer, H U; Witschi, R; Hösl, K (2009). Subtype-selective GABA(A) receptor mimetics-novel antihyperalgesic agents? Journal of Molecular Medicine, 87(5):465-469.

Knabl, J; Witschi, R; Hösl, K; Reinold, H; Zeilhofer, U B; Ahmadi, S; Brockhaus, J; Sergejeva, M; Hess, A; Brune, K; Fritschy, J M; Rudolph, U; Möhler, H; Zeilhofer, H U (2008). Reversal of pathological pain through specific spinal GABAA receptor subtypes. Nature, 451(7176):330-334.

This list was generated on Wed Aug 21 02:30:29 2019 CEST.